Titlebook: Management of Gastric Cancer; Paul H. Sugarbaker Book 1991 Kluwer Academic Publishers 1991 Staging.carcinoma.endoscopy.gastric cancer.path

Osteopenia

書目名稱Management of Gastric Cancer影響因子(影響力)




書目名稱Management of Gastric Cancer影響因子(影響力)學(xué)科排名




書目名稱Management of Gastric Cancer網(wǎng)絡(luò)公開度




書目名稱Management of Gastric Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Management of Gastric Cancer被引頻次




書目名稱Management of Gastric Cancer被引頻次學(xué)科排名




書目名稱Management of Gastric Cancer年度引用




書目名稱Management of Gastric Cancer年度引用學(xué)科排名




書目名稱Management of Gastric Cancer讀者反饋




書目名稱Management of Gastric Cancer讀者反饋學(xué)科排名

forthy

捐助

Induction chemotherapy using intraarterial infusion,ween 5 and 25% [1–8]. Gastrectomy for patients with minimal disease, as detected from mass screening programs, has achieved better results [9]. However, in North America, Europe, and Australasia, patients with minimal disease form a small proportion of the overall numbers of patients with gastric cancer when first diagnosed [10].

凌辱

Radiation therapy for gastric carcinoma,continues to be a major cause of death. Recently, adjuvant postoperative radiotherapy has been used in conjunction with chemotherapy to reduce local-regional failure in high-risk patients. Despite the use of modern megavoltage radiotherapy, normal tissue tolerance still limits the radiation dose that can be given safely.

方便

achlorhydria

GEST

沉默

Latency

Staging of gastric cancer: clinical, surgical, and pathological,ribing the anatomic extent of a tumor and whether it has spread to adjacent or distant tissues. It is generally accepted that a solid tumor has its origin in a single focus and, as time elapses, enlarges, and at some time in its development it spreads by lymphatic or blood vessels or by direct extension into other tissues [2].

EXULT

Early postoperative intraperitoneal adriamycin as an adjuvant treatment for advanced gastric cancerthat survival is reduced and peritoneal seeding plus local recurrence rates are increased in patients who have serosal invasion [3–6]. These two clinical features — (1) lymph-node positivity and (2) serosal invasion — are the strongest prognostic variables with this disease.